The CHART regimen and morbidity

Acta Oncologica

Volumn 38, Issue 2, 1999, Pages 147-152

  Dische, Stanley ^a   Saunders, Michele I ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; MORBIDITY; MUCOSA INFLAMMATION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; SKIN MANIFESTATION; TISSUE INJURY; TREATMENT OUTCOME; TUMOR REGRESSION; TUMOR VOLUME;

DOSE FRACTIONATION; HEAD AND NECK NEOPLASMS; HUMANS; MORBIDITY; MUCOUS MEMBRANE; PILOT PROJECTS; RADIODERMATITIS; RANDOMIZED CONTROLLED TRIALS; SKIN;

EID: 0032904957     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418699431546     Document Type: Article

References (12)

1. 1. Thames HD, Peters LJ, Withers HR, Fletcher GH. Accelerated fractionation vs hyperfractionation rationales for several treatments per day. Int J Radiat Oncol Biol Phys 1983; 9: 127-38.
2. 2. Saunders MI, Dische S. Radiotherapy employing three fractions in each day over a continuous period of 12 days. Br J Radiol 1986; 59: 523-5.
3. 3. Van den Bogaert W, Van Der Schueren E, Horiot JC, et al. The feasibility of high-dose multiple daily fractionation and its combination with anoxic cell sensitizers in the treatment or head and neck cancer. Int J Radiat Oncol Biol Phys 1982; 8: 1649-55.
4. 4. Fowler JF. What next in fractionated radiotherapy? Br J Cancer 1984; 49 (Suppl 6): 285-300.
5. 5. Dische S, Saunders MI. Continuous, hyperfractionated, accelerated radiotherapy (CHART): an interim report upon late morbidity. Radiother Oncol 1989; 16: 65-72.
6. 6. Leslie MD, Dische S. Parotid gland function following accelerated and conventionally fractionated radiotherapy. Radiother Oncol 1991; 22: 133-9.
7. 7. Lartigau E, Saunders MI, Dische S, Warburton MF, Des Rochers CA. A comparison of the late radiation changes after three schedules of radiotherapy. Radiother Oncol 1991; 20: 139-48.
8. 8. Turner SL, Lochrin CA, Dische S, Saunders MI, Maher EJ. Continuous hyperfractionated accelerated radiotherapy in the treatment of carcinoma of the columella and vestibule of the nose. Eur J Cancer 1995; 31B: 368-72.
9. 9. Saunders M, Dische S, Barrett A, Harvey A, Gibson A, Parmar M, on behalf of the CHART Steering Committee. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. Lancet 1997; 350: 161-6.
10. 10. Dische S, Saunders M, Barrett A, Harvey A, Gibson D, Parmar M, on behalf of the CHART Steering Committee. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 1997; 44: 123-36.
11. 11. Horiot J-C, Bontemps P, van den Bogaert W, et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol 1997; 44: 111-21.
12. 12. Maciejewski B, Skladowski K, Pilecki B, et al. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity. Radiother Oncol 1996; 40: 137-45.